News

News

Press Release

게시판 내용
GI-Cell partners with Helixmith and Cartexell to develop cell therapy technology
View : 114   |   2022-04-29

GI-Cell partners with Helixmith and Cartexell to develop cell therapy technology


GI-Cell, a South Korean developer of immune cell therapy products, has partnered with DNA and protein-based therapeutics companies to jointly develop cell therapy technologies involving immune cells to enhance disease-fighting abilities of target patients.
 
GI-Cell has signed a memorandum of understanding with Helixmith and Cartexell to develop cell therapy medicine based on an immune cell expander platform. GI-Cell hopes to target the global immune cell therapy market through collaboration.

 
"We will do our best to come up with successful achievements in the cell therapy sector through collaboration with Helixmith and Catexell with full experience, technology, and manpower," GI-Cell CEO Hong Chun-pyo said in a statement on April 28.

 

Link: https://www.ajudaily.com/view/20220429145108970 



게시판 이전/다음글
Previous post BIO-EUROPE SPRING 2022_GICELL corporate presentation
Next post No data